| Health / Medical Topics |
Recombinant Vaccinia-Tyrosinase
A recombinant vaccinia virus (based on the modified vaccinia virus Ankara) expressing tyrosinase. Tyrosinase is a melanoma-specific differentiation agent that catalyzes the synthesis of the melanin precursor dihydroxyphenylalanine (DOPA). Vaccination with this agent may evoke a melanoma-specific T-cell response. (NCI Thesaurus)
YOU MAY ALSO LIKE
A recombinant vaccinia virus encoding the melanocyte differentiation antigen tyrosinase-related protein-1 (TRP-1) with potential use in cancer immunotherapy.
A cancer vaccine made with a form of a vaccinia virus that does not cause disease in humans. It is being studied…
A recombinant vaccinia virus encoding prostate-specific antigen (PSA) and prostate-specific membrane antigen (PSMA) with potential use in cancer immunotherapy.
A recombinant vaccinia virus encoding a modified peptide of the prostate-specific antigen (PSA) with a leucine substitution at position 155, and a…
A recombinant vaccinia virus encoding prostate-specific antigen (PSA). Vaccination with recombinant vaccinia-PSA may stimulate the host immune system to mount a…
A cancer vaccine consisting of a recombinant vaccinia viral vector encoding an immunogenic peptide derived from the cancer-testis antigen NY-ESO-1, an antigen…
